A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT<sup>®</sup>) Randomized Controlled Trial - Concepedia

Concepedia

Publication | Closed Access

A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT<sup>®</sup>) Randomized Controlled Trial

341

Citations

27

References

2008

Year

Stefanie Kulnigg, S Stoĭnov, Vladimir Simanenkov, Larisa Dudar, Waldemar Karnafel, Luis Chaires Garcia, Alicia M. Sambuelli, Geert D’Haens, Christoph Gasché

The American Journal of Gastroenterology

Abstract

FeCarb is effective and safe in IBD-associated anemia. It is noninferior to FeSulf in terms of Hb change over 12 wk, and provides a fast Hb increase and a sufficient refill of iron stores.

References

	Year	Citations

Page 1